Isatuximab Plus Carfilzomib and Dexamethasone in Relapsed Multiple Myeloma Patients With High-Risk Cytogenetics: IKEMA Subgroup Analysis | OncLive
Isatuximab Plus Carfilzomib and Dexamethasone in Relapsed Multi…
1 week ago
onclive.com
Carfilzomib As Part of Upfront Therapy in Multiple Myeloma | OncLive
Carfilzomib As Part of Upfront Therapy in Multiple Myeloma | Onc…
Jun 27, 2016
onclive.com
Dr Siegel on the Use of Carfilzomib/Iberdomide/Dexamethasone Therapy in Multiple Myeloma | OncLive
Dr Siegel on the Use of Carfilzomib/Iberdomide/Dexameth…
2 weeks ago
onclive.com
Dr. Davies on the Use of Carfilzomib in Multiple Myeloma | OncLive
Dr. Davies on the Use of Carfilzomib in Multiple Myeloma | OncLive
Apr 14, 2020
onclive.com
FDA Approves Daratumumab Plus Carfilzomib and Dexamethasone for Relapsed or Refractory Multiple Myeloma
FDA Approves Daratumumab Plus Carfilzomib and Dexamethasone f…
Oct 9, 2020
ascopost.com
Carfilzomib Combination in Relapsed Multiple Myeloma
Carfilzomib Combination in Relapsed Multiple Myeloma
Jan 12, 2015
onclive.com
Dr. Stewart on the Safety Profile of Carfilzomib in Multiple Myeloma Patients
Dr. Stewart on the Safety Profile of Carfilzomib in Multiple Myeloma P…
Jan 20, 2015
onclive.com
Dr. Valent on Dose-Adjusted Carfilzomib in Myeloma
Nov 6, 2018
onclive.com
Dr. Costello on Determining Proper Dosing of Carfilzomib in Relapsed…
Jun 26, 2020
onclive.com
Dr. Fakhri on the Use of Carfilzomib in Multiple Myeloma | OncLive
Oct 16, 2018
onclive.com
Dr. Siegel on the PX-171-003-A1 Carfilzomib Study | OncLive
2 weeks ago
onclive.com
Clinical Considerations of Carfilzomib in R/R MM: CANDOR a…
1 month ago
vumedi.com
Role of Carfilzomib in Multiple Myeloma | OncLive
2 weeks ago
onclive.com
Dr. Yee on the Role of Carfilzomib in Relapsed/Refractory Multiple Myel…
May 4, 2020
onclive.com
Dr. Chari Discusses Carfilzomib Dosing in Myeloma | OncLive
Dec 5, 2018
onclive.com
Dr. Siegel on the Carfilzomib FDA Approval Process
Mar 14, 2011
onclive.com
Dr. Berenson on Carfilzomib in Refractory Multiple Myeloma | Onc…
1 week ago
onclive.com
Dr. Blue on the Utility of Carfilzomib in Relapsed/Refractory Multiple M…
Oct 1, 2021
onclive.com
ASCO® 2025 Insights: Carfilzomib, Iberdomide, and Dexamethasone (…
1 month ago
vumedi.com
ASCO® 2025 Insights: Carfilzomib, Lenalidomide and Dex (KRd) /- Dar…
99 views4 months ago
vumedi.com
4:18
Isatuximab, carfilzomib, and dexamethasone in relapsed multip…
1.2K viewsJun 7, 2021
YouTubeThe Lancet
Carfilzomib (5a, Kyprolis) is a proteasome inhibitor for the tr... | …
3 months ago
askfilo.com
16:50
All About Kyprolis (Carfilzomib)- A Proteasome Inhibitor for Multiple …
785 views2 months ago
YouTubeHealthTree University for Multiple Myeloma
7:31
Linvoseltamab+Carfilzomib in Relapsed/Refractory Multiple Myel…
182 views2 months ago
YouTubeInternational Myeloma Foundation
1:10
Dr. Chari Discusses Carfilzomib Dosing in Myeloma
496 viewsDec 4, 2018
YouTubeOncLive
2:43
The safety and efficacy of carfilzomib-lenalidomide-dexamet…
122 viewsJun 16, 2022
YouTubeVJHemOnc – Video Journal of Hematology & H…
52:37
Know Your Myeloma Therapy: Carfilzomib (Kyprolis) with Dr. Har…
1.5K viewsJan 21, 2022
YouTubeHealthTree Foundation
2:17
Dr Hernandez-Ilizaliturri on the Use of CAR T-Cell Therapy in R/R Multi…
116 viewsAug 19, 2024
YouTubeOncLive
1:30
Dr. Yee on the Role of Carfilzomib in Relapsed/Refractory Multiple Myel…
134 viewsMay 4, 2020
YouTubeOncLive
3:52
Elranatamab + Carfilzomib: Results in Relapsed/Refractory #Myeloma …
310 views9 months ago
YouTubeHealthTree Foundation
See more videos
Static thumbnail place holder